Annual report pursuant to Section 13 and 15(d)

NON CONTROLLING INTEREST (Details)

v3.20.1
NON CONTROLLING INTEREST (Details) - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Net loss attributable to the non-controlling interest $ (8,691) $ (72,487)
BioCorRx Pharmaceuticals, Inc [Member]    
Net loss (35,914) (299,533)
Net loss attributable to the non-controlling interest $ (8,691) $ (72,487)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20%